Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 675

1.

Heart Rate Reduction after Exercise Is Associated with Arrhythmic Events in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia.

Lieve KVV, Dusi V, van der Werf C, Bos JM, Lane CM, Stokke MK, Roston TM, Djupsjöbacka A, Wada Y, Denjoy I, Bundgaard H, Rosés I Noguer F, Semsarian C, Robyns T, Hofman N, Tanck MW, van den Berg MP, Kammeraad JAE, Krahn AD, Clur SB, Sacher F, Till J, Skinner JR, Tfelt-Hansen J, Probst V, Leenhardt A, Horie M, Swan H, Roberts JD, Sanatani S, Haugaa KH, Schwartz PJ, Ackerman MJ, Wilde AAM.

Circ Arrhythm Electrophysiol. 2020 Feb 16. doi: 10.1161/CIRCEP.119.007471. [Epub ahead of print]

PMID:
32063070
2.

Clinical and Functional Reappraisal of Alleged Type 5 Long QT Syndrome-Causative Genetic Variants in the KCNE1-Encoded minK β-Subunit.

Garmany R, Giudicessi JR, Ye D, Zhou W, Tester DJ, Ackerman MJ.

Heart Rhythm. 2020 Feb 10. pii: S1547-5271(20)30092-8. doi: 10.1016/j.hrthm.2020.02.003. [Epub ahead of print]

PMID:
32058015
3.

An International, Multicentered, EvidenceBased Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome.

Adler A, Novelli V, Amin AS, Abiusi E, Care M, Nannenberg EA, Feilotter H, Amenta S, Mazza D, Bikker H, Sturm AC, Garcia J, Ackerman MJ, Hershberger RE, Perez MV, Zareba W, Ware JS, Wilde AAM, Gollob MH.

Circulation. 2020 Jan 27. doi: 10.1161/CIRCULATIONAHA.119.043132. [Epub ahead of print] No abstract available.

PMID:
31983240
4.

An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition.

Roberts JD, Asaki SY, Mazzanti A, Bos JM, Tuleta I, Muir AR, Crotti L, Krahn AD, Kutyifa V, Shoemaker MB, Johnsrude CL, Aiba T, Marcondes L, Baban A, Udupa S, Dechert B, Fischbach P, Knight LM, Vittinghoff E, Kukavica D, Stallmeyer B, Giudicessi JR, Spazzolini C, Shimamoto K, Tadros R, Cadrin-Tourigny J, Duff HJ, Simpson CS, Roston TM, Wijeyeratne YD, El Hajjaji I, Yousif MD, Gula LJ, Leong-Sit P, Chavali N, Landstrom AP, Marcus GM, Dittmann S, Wilde AAM, Behr ER, Tfelt-Hansen J, Scheinman MM, Perez MV, Kaski JP, Gow RM, Drago F, Aziz PF, Abrams DJ, Gollob MH, Skinner JR, Shimizu W, Kaufman ES, Roden DM, Zareba W, Schwartz PJ, Schulze-Bahr E, Etheridge SP, Priori SG, Ackerman MJ.

Circulation. 2020 Jan 16. doi: 10.1161/CIRCULATIONAHA.119.043114. [Epub ahead of print]

PMID:
31941373
5.

Identification of a Novel Homozygous Multi-Exon Duplication in RYR2 Among Children With Exertion-Related Unexplained Sudden Deaths in the Amish Community.

Tester DJ, Bombei HM, Fitzgerald KK, Giudicessi JR, Pitel BA, Thorland EC, Russell BG, Hamrick SK, Kim CSJ, Haglund-Turnquist CM, Johnsrude CL, Atkins DL, Ochoa Nunez LA, Law I, Temple J, Ackerman MJ.

JAMA Cardiol. 2020 Jan 8. doi: 10.1001/jamacardio.2019.5400. [Epub ahead of print]

PMID:
31913406
6.

Systematic Review of the Genetics of Sudden Unexpected Death in Epilepsy: Potential Overlap With Sudden Cardiac Death and Arrhythmia-Related Genes.

Chahal CAA, Salloum MN, Alahdab F, Gottwald JA, Tester DJ, Anwer LA, So EL, Murad MH, St Louis EK, Ackerman MJ, Somers VK.

J Am Heart Assoc. 2020 Jan 7;9(1):e012264. doi: 10.1161/JAHA.119.012264. Epub 2019 Dec 21.

7.

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary.

Towbin JA, McKenna WJ, Abrams DJ, Ackerman MJ, Calkins H, Darrieux FCC, Daubert JP, de Chillou C, DePasquale EC, Desai MY, Estes NAM 3rd, Hua W, Indik JH, Ingles J, James CA, John RM, Judge DP, Keegan R, Krahn AD, Link MS, Marcus FI, McLeod CJ, Mestroni L, Priori SG, Saffitz JE, Sanatani S, Shimizu W, van Tintelen JP, Wilde AAM, Zareba W.

Heart Rhythm. 2019 Nov;16(11):e373-e407. doi: 10.1016/j.hrthm.2019.09.019.

PMID:
31676023
8.

MRAS Variants Cause Cardiomyocyte Hypertrophy in Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Additional Evidence for MRAS as a Definitive Noonan Syndrome-Susceptibility Gene.

Higgins EM, Bos JM, Dotzler SM, John Kim CS, Ackerman MJ.

Circ Genom Precis Med. 2019 Nov;12(11):e002648. doi: 10.1161/CIRCGEN.119.002648. Epub 2019 Oct 22.

PMID:
31638832
9.

Stellate ganglion block and cardiac sympathetic denervation in patients with inappropriate sinus tachycardia.

Cha YM, Li X, Yang M, Han J, Wu G, Kapa SC, McLeod CJ, Noseworthy PA, Mulpuru SK, Asirvatham SJ, Brady PA, Rho RH, Friedman PA, Lee HC, Tian Y, Zhou S, Munger TM, Ackerman MJ, Shen WK.

J Cardiovasc Electrophysiol. 2019 Dec;30(12):2920-2928. doi: 10.1111/jce.14233. Epub 2019 Nov 6.

10.

The Effect of Left Cardiac Sympathetic Denervation on Exercise in Patients With Long QT Syndrome.

Anderson HN, Bos JM, Rohatgi RK, Ackerman MJ.

JACC Clin Electrophysiol. 2019 Sep;5(9):1084-1090. doi: 10.1016/j.jacep.2019.06.008.

PMID:
31537339
11.

Mothers with long QT syndrome are at increased risk for fetal death: findings from a multicenter international study.

Cuneo BF, Kaizer AM, Clur SA, Swan H, Herberg U, Winbo A, Rydberg A, Haugaa K, Etheridge S, Ackerman MJ, Dagradi F, Killen SAS, Wacker-Gussmann A, Benson DW, Wilde AAM, Pan Z, Lam A, Spazzolini C, Horigome H, Schwartz PJ; Fetal LQTS Consortium.

Am J Obstet Gynecol. 2019 Sep 11. pii: S0002-9378(19)31109-3. doi: 10.1016/j.ajog.2019.09.004. [Epub ahead of print]

PMID:
31520628
12.

Effective Use of Percutaneous Stellate Ganglion Blockade in Patients With Electrical Storm.

Tian Y, Wittwer ED, Kapa S, McLeod CJ, Xiao P, Noseworthy PA, Mulpuru SK, Deshmukh AJ, Lee HC, Ackerman MJ, Asirvatham SJ, Munger TM, Liu XP, Friedman PA, Cha YM.

Circ Arrhythm Electrophysiol. 2019 Sep;12(9):e007118. doi: 10.1161/CIRCEP.118.007118. Epub 2019 Sep 13.

PMID:
31514529
13.

Utilization of the genome aggregation database, in silico tools, and heterologous expression patch-clamp studies to identify and demote previously published type 2 long QT syndrome: Causative variants from pathogenic to likely benign.

Mattivi CL, Ye D, Tester DJ, Clemens DJ, Zhou W, Giudicessi JR, Ackerman MJ.

Heart Rhythm. 2020 Feb;17(2):315-323. doi: 10.1016/j.hrthm.2019.08.014. Epub 2019 Sep 5.

PMID:
31493592
14.

Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation.

Estes SI, Ye D, Zhou W, Dotzler SM, Tester DJ, Bos JM, Kim CSJ, Ackerman MJ.

Circ Genom Precis Med. 2019 Aug;12(8):e002534. doi: 10.1161/CIRCGEN.119.002534. Epub 2019 Aug 20.

PMID:
31430211
15.

Evaluation After Sudden Death in the Young.

Gray B, Ackerman MJ, Semsarian C, Behr ER.

Circ Arrhythm Electrophysiol. 2019 Aug;12(8):e007453. doi: 10.1161/CIRCEP.119.007453. Epub 2019 Aug 19.

PMID:
31422686
16.

Type 8 long QT syndrome: pathogenic variants in CACNA1C-encoded Cav1.2 cluster in STAC protein binding site.

Mellor GJ, Panwar P, Lee AK, Steinberg C, Hathaway JA, Bartels K, Christian S, Balaji S, Roberts JD, Simpson CS, Boczek NJ, Tester DJ, Radbill AE, Mok NS, Hamilton RM, Kaufman ES, Eugenio PL, Weiss R, January C, McDaniel GM, Leather RA, Erickson C, Falik S, Behr ER, Wilde AAM, Sanatani S, Ackerman MJ, Van Petegem F, Krahn AD, Laksman Z.

Europace. 2019 Nov 1;21(11):1725-1732. doi: 10.1093/europace/euz215.

PMID:
31408100
17.

Findings of Uncertain Significance and a Family History of Sudden Death: Worth the FUSs?

Ackerman MJ, Giudicessi JR.

J Am Coll Cardiol. 2019 Aug 13;74(6):771-773. doi: 10.1016/j.jacc.2019.06.042. No abstract available.

PMID:
31395127
18.

In reply-Strategies of Screening for Fabry Disease in Patients With Unexplained Left Ventricular Hypertrophy.

Newman DB, Ackerman MJ.

Mayo Clin Proc. 2019 Aug;94(8):1646. doi: 10.1016/j.mayocp.2019.05.004. No abstract available.

PMID:
31378242
19.

Left cardiac sympathetic denervation for recurrent ventricular tachyarrhythmias in children with congenital heart disease.

Bonura ED, Moir C, Ackerman MJ, Wackel P.

HeartRhythm Case Rep. 2019 May 3;5(7):392-394. doi: 10.1016/j.hrcr.2019.04.007. eCollection 2019 Jul. No abstract available.

20.

Pediatric-Onset Arrhythmogenic Cardiomyopathy: Look Right, Look Left, Look Both Ways.

Ackerman MJ, Giudicessi JR.

J Am Coll Cardiol. 2019 Jul 23;74(3):359-361. doi: 10.1016/j.jacc.2019.05.023. No abstract available.

PMID:
31319918
21.

QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia.

Barreto JN, Cullen MW, Mara KC, Grove ME, Sierzchulski AG, Dahl NJ, Tosh PK, Dierkhising RA, Patnaik MM, Ackerman MJ.

Leuk Lymphoma. 2019 Dec;60(14):3512-3520. doi: 10.1080/10428194.2019.1639165. Epub 2019 Jul 12.

PMID:
31298598
22.

Electrophysiologic effects and outcomes of sympatholysis in patients with recurrent ventricular arrhythmia and structural heart disease.

Cai C, Dai MY, Tian Y, Zhang P, Wittwer ED, Rho RH, Kapa S, McLeod CJ, Mulpuru SK, Lee HC, Ackerman MJ, Asirvatham SJ, Munger TM, Chen ML, Friedman PA, Cha YM.

J Cardiovasc Electrophysiol. 2019 Sep;30(9):1499-1507. doi: 10.1111/jce.14030. Epub 2019 Jul 4.

PMID:
31199536
23.

The QT Interval.

Giudicessi JR, Noseworthy PA, Ackerman MJ.

Circulation. 2019 Jun 11;139(24):2711-2713. doi: 10.1161/CIRCULATIONAHA.119.039598. Epub 2019 Jun 10. No abstract available.

PMID:
31180747
24.

Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry.

Crotti L, Spazzolini C, Tester DJ, Ghidoni A, Baruteau AE, Beckmann BM, Behr ER, Bennett JS, Bezzina CR, Bhuiyan ZA, Celiker A, Cerrone M, Dagradi F, De Ferrari GM, Etheridge SP, Fatah M, Garcia-Pavia P, Al-Ghamdi S, Hamilton RM, Al-Hassnan ZN, Horie M, Jimenez-Jaimez J, Kanter RJ, Kaski JP, Kotta MC, Lahrouchi N, Makita N, Norrish G, Odland HH, Ohno S, Papagiannis J, Parati G, Sekarski N, Tveten K, Vatta M, Webster G, Wilde AAM, Wojciak J, George AL, Ackerman MJ, Schwartz PJ.

Eur Heart J. 2019 Sep 14;40(35):2964-2975. doi: 10.1093/eurheartj/ehz311.

PMID:
31170290
25.

Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest.

van der Werf C, Lieve KV, Bos JM, Lane CM, Denjoy I, Roses-Noguer F, Aiba T, Wada Y, Ingles J, Leren IS, Rudic B, Schwartz PJ, Maltret A, Sacher F, Skinner JR, Krahn AD, Roston TM, Tfelt-Hansen J, Swan H, Robyns T, Ohno S, Roberts JD, van den Berg MP, Kammeraad JA, Probst V, Kannankeril PJ, Blom NA, Behr ER, Borggrefe M, Haugaa KH, Semsarian C, Horie M, Shimizu W, Till JA, Leenhardt A, Ackerman MJ, Wilde AA.

Eur Heart J. 2019 Sep 14;40(35):2953-2961. doi: 10.1093/eurheartj/ehz309.

PMID:
31145795
26.

Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association.

Ahmad F, McNally EM, Ackerman MJ, Baty LC, Day SM, Kullo IJ, Madueme PC, Maron MS, Martinez MW, Salberg L, Taylor MR, Wilcox JE.

Circ Genom Precis Med. 2019 Jun;12(6):e000054. doi: 10.1161/HCG.0000000000000054. Epub 2019 May 23.

PMID:
31117808
27.

Assessment and Validation of a Phenotype-Enhanced Variant Classification Framework to Promote or Demote RYR2 Missense Variants of Uncertain Significance.

Giudicessi JR, Lieve KVV, Rohatgi RK, Koca F, Tester DJ, van der Werf C, Martijn Bos J, Wilde AAM, Ackerman MJ.

Circ Genom Precis Med. 2019 May;12(5):e002510. doi: 10.1161/CIRCGEN.119.002510.

PMID:
31112425
28.

2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.

Towbin JA, McKenna WJ, Abrams DJ, Ackerman MJ, Calkins H, Darrieux FCC, Daubert JP, de Chillou C, DePasquale EC, Desai MY, Estes NAM 3rd, Hua W, Indik JH, Ingles J, James CA, John RM, Judge DP, Keegan R, Krahn AD, Link MS, Marcus FI, McLeod CJ, Mestroni L, Priori SG, Saffitz JE, Sanatani S, Shimizu W, van Tintelen JP, Wilde AAM, Zareba W.

Heart Rhythm. 2019 Nov;16(11):e301-e372. doi: 10.1016/j.hrthm.2019.05.007. Epub 2019 May 9.

PMID:
31078652
29.

Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome.

Bos JM, Crotti L, Rohatgi RK, Castelletti S, Dagradi F, Schwartz PJ, Ackerman MJ.

Circ Arrhythm Electrophysiol. 2019 May;12(5):e007280. doi: 10.1161/CIRCEP.118.007280.

PMID:
31006312
30.

Survival After Myectomy for Obstructive Hypertrophic Cardiomyopathy: What Causes Late Mortality?

Nguyen A, Schaff HV, Nishimura RA, Geske JB, Ackerman MJ, Bos JM, Dearani JA, Ommen SR.

Ann Thorac Surg. 2019 Sep;108(3):723-729. doi: 10.1016/j.athoracsur.2019.03.026. Epub 2019 Apr 9.

PMID:
30978316
31.

Development and Validation of a Deep-Learning Model to Screen for Hyperkalemia From the Electrocardiogram.

Galloway CD, Valys AV, Shreibati JB, Treiman DL, Petterson FL, Gundotra VP, Albert DE, Attia ZI, Carter RE, Asirvatham SJ, Ackerman MJ, Noseworthy PA, Dillon JJ, Friedman PA.

JAMA Cardiol. 2019 May 1;4(5):428-436. doi: 10.1001/jamacardio.2019.0640.

PMID:
30942845
32.

A Novel Truncating Variant in FLNC-Encoded Filamin C May Serve as a Proarrhythmic Genetic Substrate for Arrhythmogenic Bileaflet Mitral Valve Prolapse Syndrome.

Bains S, Tester DJ, Asirvatham SJ, Noseworthy PA, Ackerman MJ, Giudicessi JR.

Mayo Clin Proc. 2019 May;94(5):906-913. doi: 10.1016/j.mayocp.2018.11.028. Epub 2019 Mar 29.

PMID:
30935706
33.
34.

Is variant pathogenicity in the eye of the beholder? A case of unexplained sudden cardiac arrest highlights the potentially dangerous role of historical rare variant compendia in SCN5A rare variant adjudication.

Stutzman MJ, Ye D, Tester DJ, Giudicessi JR, Ackerman MJ.

HeartRhythm Case Rep. 2018 Dec 11;5(3):163-168. doi: 10.1016/j.hrcr.2018.11.019. eCollection 2019 Mar. No abstract available.

35.

Shared Decision Making for Athletes with Cardiovascular Disease: Practical Considerations.

Baggish AL, Ackerman MJ, Putukian M, Lampert R.

Curr Sports Med Rep. 2019 Mar;18(3):76-81. doi: 10.1249/JSR.0000000000000575.

PMID:
30855305
36.

Cardiac hypertrophy and arrhythmia in mice induced by a mutation in ryanodine receptor 2.

Alvarado FJ, Bos JM, Yuchi Z, Valdivia CR, Hernández JJ, Zhao YT, Henderlong DS, Chen Y, Booher TR, Marcou CA, Van Petegem F, Ackerman MJ, Valdivia HH.

JCI Insight. 2019 Mar 5;5. pii: 126544. doi: 10.1172/jci.insight.126544.

37.

Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with MYL2-R58Q-Mediated Apical Hypertrophic Cardiomyopathy Show Hypertrophy, Myofibrillar Disarray, and Calcium Perturbations.

Zhou W, Bos JM, Ye D, Tester DJ, Hrstka S, Maleszewski JJ, Ommen SR, Nishimura RA, Schaff HV, Kim CS, Ackerman MJ.

J Cardiovasc Transl Res. 2019 Oct;12(5):394-403. doi: 10.1007/s12265-019-09873-6. Epub 2019 Feb 22.

PMID:
30796699
38.

Human Fibrinogen for Maintenance and Differentiation of Induced Pluripotent Stem Cells in Two Dimensions and Three Dimensions.

Gandhi JK, Knudsen T, Hill M, Roy B, Bachman L, Pfannkoch-Andrews C, Schmidt KN, Metko MM, Ackerman MJ, Resch Z, Pulido JS, Marmorstein AD.

Stem Cells Transl Med. 2019 Jun;8(6):512-521. doi: 10.1002/sctm.18-0189. Epub 2019 Feb 15.

39.

Exercise testing oversights underlie missed and delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia in young sudden cardiac arrest survivors.

Giudicessi JR, Ackerman MJ.

Heart Rhythm. 2019 Aug;16(8):1232-1239. doi: 10.1016/j.hrthm.2019.02.012. Epub 2019 Feb 11.

PMID:
30763784
40.

Plakophilin-2 Truncation Variants in Patients Clinically Diagnosed With Catecholaminergic Polymorphic Ventricular Tachycardia and Decedents With Exercise-Associated Autopsy Negative Sudden Unexplained Death in the Young.

Tester DJ, Ackerman JP, Giudicessi JR, Ackerman NC, Cerrone M, Delmar M, Ackerman MJ.

JACC Clin Electrophysiol. 2019 Jan;5(1):120-127. doi: 10.1016/j.jacep.2018.09.010. Epub 2018 Nov 1.

41.

International Triadin Knockout Syndrome Registry.

Clemens DJ, Tester DJ, Giudicessi JR, Bos JM, Rohatgi RK, Abrams DJ, Balaji S, Crotti L, Faure J, Napolitano C, Priori SG, Probst V, Rooryck-Thambo C, Roux-Buisson N, Sacher F, Schwartz PJ, Silka MJ, Walsh MA, Ackerman MJ.

Circ Genom Precis Med. 2019 Feb;12(2):e002419. doi: 10.1161/CIRCGEN.118.002419.

PMID:
30649896
42.

Cost Efficacy of α-Galactosidase A Enzyme Screening for Fabry Disease.

Newman DB, Miranda WR, Matern D, Peck DS, Geske JB, Maleszewski JJ, Ommen SR, Ackerman MJ.

Mayo Clin Proc. 2019 Jan;94(1):84-88. doi: 10.1016/j.mayocp.2018.08.009.

PMID:
30611458
43.

Long QT syndrome caveolin-3 mutations differentially modulate Kv 4 and Cav 1.2 channels to contribute to action potential prolongation.

Tyan L, Foell JD, Vincent KP, Woon MT, Mesquitta WT, Lang D, Best JM, Ackerman MJ, McCulloch AD, Glukhov AV, Balijepalli RC, Kamp TJ.

J Physiol. 2019 Mar;597(6):1531-1551. doi: 10.1113/JP276014. Epub 2019 Jan 24.

PMID:
30588629
44.

Safety of Sports for Young Patients With Implantable Cardioverter-Defibrillators.

Saarel EV, Law I, Berul CI, Ackerman MJ, Kanter RJ, Sanatani S, Cohen MI, Berger S, Fischbach PS, Burton DA, Dziura J, Brandt C, Simone L, Li F, Olshansky B, Cannom DS, Lampert RJ.

Circ Arrhythm Electrophysiol. 2018 Nov;11(11):e006305. doi: 10.1161/CIRCEP.118.006305.

PMID:
30520349
45.

Effect of Ascertainment Bias on Estimates of Patient Mortality in Inherited Cardiac Diseases.

Nannenberg EA, van Rijsingen IAW, van der Zwaag PA, van den Berg MP, van Tintelen JP, Tanck MWT, Ackerman MJ, Wilde AAM, Christiaans I.

Circ Genom Precis Med. 2018 Oct;11(10):e001797. doi: 10.1161/CIRCGEN.117.001797.

PMID:
30354299
46.

Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.

Naksuk N, Sugrue AM, Padmanabhan D, Kella D, DeSimone CV, Kapa S, Asirvatham SJ, Lee HC, Ackerman MJ, Noseworthy PA.

J Interv Card Electrophysiol. 2019 Mar;54(2):189-196. doi: 10.1007/s10840-018-0476-2. Epub 2018 Oct 23.

PMID:
30353374
47.

Exome-Wide Rare Variant Analyses in Sudden Infant Death Syndrome.

Tester DJ, Wong LCH, Chanana P, Gray B, Jaye A, Evans JM, Evans M, Fleming P, Jeffrey I, Cohen M, Tfelt-Hansen J, Simpson MA, Behr ER, Ackerman MJ.

J Pediatr. 2018 Dec;203:423-428.e11. doi: 10.1016/j.jpeds.2018.08.011. Epub 2018 Sep 26.

48.

An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis.

Chatterjee D, Fatah M, Akdis D, Spears DA, Koopmann TT, Mittal K, Rafiq MA, Cattanach BM, Zhao Q, Healey JS, Ackerman MJ, Bos JM, Sun Y, Maynes JT, Brunckhorst C, Medeiros-Domingo A, Duru F, Saguner AM, Hamilton RM.

Eur Heart J. 2018 Nov 21;39(44):3932-3944. doi: 10.1093/eurheartj/ehy567.

49.

Clinical Significance of Early Repolarization in Long QT Syndrome.

Sugrue A, Rohatgi RK, Bos M, Vaidya VR, Asirvatham SJ, Noseworthy PA, Ackerman MJ.

JACC Clin Electrophysiol. 2018 Sep;4(9):1238-1244. doi: 10.1016/j.jacep.2018.06.007. Epub 2018 Aug 29.

50.

Prevalence and clinical phenotype of concomitant long QT syndrome and arrhythmogenic bileaflet mitral valve prolapse.

Giudicessi JR, Rohatgi RK, Bos JM, Ackerman MJ.

Int J Cardiol. 2019 Jan 1;274:175-178. doi: 10.1016/j.ijcard.2018.09.046. Epub 2018 Sep 11.

PMID:
30219255

Supplemental Content

Loading ...
Support Center